Wise Medical (688580.SH) Plans to Permanently Supplement Working Capital with RMB 179 Million of Excess IPO Proceeds

Gelonghui, April 7 |VISHEENanjing Vishee Medical Technology Co., Ltd. (688580.SH) announced that, to meet the company’s working capital needs, improve the utilization efficiency of raised funds, and reduce financial costs, it plans to use RMB 179 million from excess proceeds to permanently supplement working capital for its production and operations. This measure aligns with the actual development needs of the company’s operations and serves the interests of all shareholders.